Chronic Inflammatory Demyelinating Polyneuropathy
The Chronic Inflammatory Demyelinating Polyneuropathy pipeline: 5 tracked drugs, 1 approved for this indication.
Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Chronic Inflammatory Demyelinating Polyneuropathy, so this list is not complete.
1 approved / phase 41 Phase 31 Phase 22 preclinical / unstaged
Compare the share prices of listed companies in Chronic Inflammatory Demyelinating Polyneuropathy →
Market size not yet sourced. How markets are sized ↗